Please login to the form below

Not currently logged in
Email:
Password:

financial results

This page shows the latest financial results news and features for those working in and with pharma, biotech and healthcare.

Lynparza cleared for first-line ovarian cancer use in China

Lynparza cleared for first-line ovarian cancer use in China

The approval is based on the results from AZ’s phase 3 SOLO-1 trial, which showed Lynparza reduced the risk of disease progression or death by 70% in these patients ... It is also one of AZ’s star performers – in its third-quarter financial results

Latest news

  • Takeda’s dengue vaccine seems safe with no prior virus exposure Takeda’s dengue vaccine seems safe with no prior virus exposure

    more poorly, according to results  published in the New England Journal of Medicine. ... Since then sales of Dengvaxia – once tipped to become a blockbuster – have been too low to warrant a separate line in Sanofi’s financial results statements.

  • Merck CFO: we’re not only about Keytruda Merck CFO: we’re not only about Keytruda

    Predictably, discussion of Keytruda’s massive clinical trials programme dominated Merck’s third-quarter results call. ... Meanwhile, AZ has just reported positive top-line results with Imfinzi (durvalumab) plus experimental CTLA4 tremelimumab in

  • Gilead promotes Andrew Dickinson to CFO, increased M&A expected Gilead promotes Andrew Dickinson to CFO, increased M&A expected

    Andy is an exceptional, highly strategic leader. In addition to his impressive business and financial acumen and broad experience, Andy possesses strong creativity and vision. ... Dickinson will succeed current CFO Robin Washington, who will remain at

  • Litigation concerns threaten to overshadow solid quarter at J&J Litigation concerns threaten to overshadow solid quarter at J&J

    Reports better-than-expected financial results. Johnson &Johnson has posted a better-than-expected set of financial results for the third quarter that has been overshadowed by product liability litigation. ... Chief financial officer Joseph Wolk

  • Opdivo trial overshadows BMS financial results Opdivo trial overshadows BMS financial results

    Hope remains in Celgene merger. Bristol-Myers Squibb posted a 10% increase in revenues in the second quarter, but reporting focused on mixed results in a trial of its main growth ... patients” and would be discussing the results with regulators “as

More from news
Approximately 70 fully matching, plus 118 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    some financial companies to re-emerge as Barbarians.  The 2008 financial crash is a salutary reminder. ... What happens next?    Assuming the deal is completed, DW predicts the new Stada will start to hunt for product and company acquisitions to

  • Deal Watch August 2016 Deal Watch August 2016

    company rather than seeking a short term financial 'fix' to improve its financial results.”. ... In the same way that the asset acquisition deal between AstraZeneca and Pfizer had the financial structure of a licence, so too does the Pfizer acquisition

  • Technology: the missing link in true patient engagement? Technology: the missing link in true patient engagement?

    This comes at a huge financial cost, and results in suboptimal patient outcomes. ... While manual adherence programmes with assigned nurses have yielded positive outcomes, it isn't always possible to provide this widely due to financial and resource

  • Deal Watch April 2016 Deal Watch April 2016

    term financial 'fix' to improve its financial results. ... The deal with Nimbus did not excite investors and they were even less impressed when Gilead reported first quarter results showing sales growth of 4% and full year guidance of $30bn

  • Who tops the pharma list? Who tops the pharma list?

    Chris Ross, with the help of healthcare analysts GlobalData, takes a New Year look at the past, present and future of global pharma, and asks: what’s trending? 

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...

Infographics